| Literature DB >> 21477140 |
Abstract
BACKGROUND: Two important challenges to the use of serological assays for influenza surveillance include the substantial amount of experimental effort involved and the inherent noisiness of serological data.Entities:
Mesh:
Year: 2011 PMID: 21477140 PMCID: PMC4986581 DOI: 10.1111/j.1750-2659.2010.00192.x
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 4.380
Figure 1Dimensionality and recoverability of noise‐free titers. (A) The dimensionality of each of 23 tables of empirical titers (Table S1) was investigated by log‐transforming the titers found in each table and subsequently determining the fraction of the variation in titers (denoted F r) that is explained by the eigenvectors associated with the r largest singular values of each table (Methods). F r (averaged over all 23 tables) is plotted against r, for r = 1,…,5. (B) A table consisting of simulated titers was contaminated by noise (independently drawn from a normal distribution with mean 0 and standard deviation δ), and the resulting noisy titers were used to compute estimates of and 95% CIs for the uncontaminated (or noise‐free) titers (Methods). The fraction of noise‐free titers that occurred within their corresponding CIs is plotted against δ. (C) The mean ratio of the width of the 95% CI for a particular noise‐free titer to the absolute value of that titer is plotted against δ. (D) The mean absolute difference between the estimated and noise‐free titers, between the estimated and noisy titers, and between the noisy and noise‐free titers, is plotted against δ. Bars denote standard deviations.
Figure 2One‐dimensional serological map of 123 H1N1 viruses. Four tables of titers (Supplementary Data S1) that were recently collected by the US. Centers for Disease Control and Prevention were analyzed. The tables had dimensions 26 by 10, 36 by 10, 40 by 12, and 41 by 11, respectively. Between 10% and 26% of titers were missing from each table. Measured titers found in each table were log‐transformed and used to recover the missing titers, except for titers missing from rows/columns in which fewer than two titers were measured. (In particular, titers for the Brisbane/59/07 virus were not recovered). Each completed table was row‐centered and used to quantify differences between the serological responses of pairs of viruses (Methods). These serological (or ‘antigenic’) differences were subsequently mapped onto a one‐dimensional space by means of probabilistic multidimensional scaling (Part 2 of SI). The viral coordinates thus obtained are shown in the plot. The width of each displayed rectangle represents a unit of serological difference. The novel H1N1 vaccine virus (CA09) is labeled, as are five other viruses that were isolated before 2009. The arrow indicates the apparent direction of temporal changes in the serological properties of the analyzed viruses. Virus labels: CA09 California 07/2009, IL07 Illinois/9(33304)/2007, NJ76 New Jersey/8/1976, SW30 Swine/Iowa/1930, TX08 Texas/14/2008, WI98 Wisconsin/10/1998.